MLYS FY 2023 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

MLYSMineralys Therapeutics, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$85M

Net Income

-$72M

EPS (Diluted)

$-1.99

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$81M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$252M

Total Liabilities

$10M

Stockholders' Equity

$241M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$85M	-$31M	-168.9%
Net Income	-$72M	-$30M	-141.3%